Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06628934 · ClinicalTrials.gov registry record
Wearable Gait Sensors
A clinical trial of Spinocerebellar Ataxia, sponsored by University of Chicago.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT06628934 is a study of Spinocerebellar Ataxia that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 600 participants, above the 16-participant average among 3 other Spinocerebellar Ataxia trials with a reported enrollment target (3650% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06628934, a study of Spinocerebellar Ataxia, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is testing body-worn sensors to measure movement during simple tests of coordination, in order to evaluate the progression and severity of Spinocerebellar ataxia.
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-06-23 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06628934
The ClinicalTrials.gov registry entry for NCT06628934 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 16-participant average among 3 other Spinocerebellar Ataxia trials with a reported enrollment target (3650% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinocerebellar Ataxia appearing as the primary indexed condition, and to 0 interventions.
NCT06628934 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06628934 about?
NCT06628934 is a clinical study titled "Wearable Gait Sensors". This research study is testing body-worn sensors to measure movement during simple tests of coordination, in order to evaluate the progression and severity of Spinocerebellar ataxia.
What is the current status of trial NCT06628934?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2017-06-23. Estimated completion is 2026-12-31.
What conditions does trial NCT06628934 study?
This clinical trial studies the following conditions: Spinocerebellar Ataxia.
Who is sponsoring clinical trial NCT06628934?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06628934 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinocerebellar Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.